Athens General Hospital 'Evangelismos' is one of the largest public hospitals in Greece. It is located in a sub-neighbourhood of Kolonaki named after it, Evangelismos.

During the past decade, General Hospital of Athens "Evangelismos" conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 26 clinical trials were completed, i.e. on average, 29.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 22 clinical trials were completed. i.e. 52.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital of Athens "Evangelismos"" #1 sponsor was "Evangelismos Hospital" with 15 trials, followed by "Celgene" with 13 trials sponsored, "University of Athens" with 10 trials sponsored, "Amgen" with 9 trials sponsored and "Takeda" with 9 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Athens "Evangelismos"" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "University of Thessaly" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Janssen Research & Development, LLC" with 2 trials as a collaborator and "NEAT - European AIDS Treatment Network" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital of Athens "Evangelismos"" are "Multiple Myeloma" (17 trials), "Acute Respiratory Distress Syndrome" (6 trials), "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials) and "Analgesia" (3 trials). Many other conditions were trialed in "General Hospital of Athens "Evangelismos"" in a lesser frequency.

Most popular intervention types in "General Hospital of Athens "Evangelismos"" are "Drug" (78 trials), "Other" (20 trials), "Device" (9 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Dexamethasone" (16 trials), "Pomalidomide" (7 trials), "Bortezomib" (6 trials) and "Daratumumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Athens "Evangelismos"" are 117 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "General Hospital of Athens "Evangelismos"". 4 are not yet recruiting, 25 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in General Hospital of Athens "Evangelismos", undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Athens "Evangelismos", 6 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".